Owners, management and financials
CVR: 32770487
Previous names: ApS KBURS 17 NR. 6965
DKK -9,158,236
Gross profit
Net result: DKK -21,948,253
Expres2ion Biotech Holding AB (100%)
CVR · view owners
Bent Ulrich Frandsen
Board: Martin Roland Jensen (chair) and 3 members
CVR · view management
Active
Founded 1 January 2010
CVR · view overview
18 employees
CVR · 2018
Director registered: Bent Ulrich Frandsen
CVR · 20/12/2019
View the full event history
EXPRES2ION BIOTECHNOLOGIES ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ApS KBURS 17 NR. 6965. The management consists of Bent Ulrich Frandsen. The board consists of Martin Roland Jensen (chair), Jakob Ole Knudsen, Karin Garre and Michel Jean Baijot. The company is owned by Expres2ion Biotech Holding AB. The company has 18 employees (2018). In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262.
Selskabets formål er at drive virksomhed indenfor bioteknologi
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -9.2 mio. | -21.9 mio. | 43.6 mio. | 24 mio. | 18 | |
| 202401/01/2024 – 31/12/2024 | -24 mio. | -19.8 mio. | 58 mio. | 32.8 mio. | 17 | |
| 202301/01/2023 – 31/12/2023 | -38.9 mio. | -55.6 mio. | 50.2 mio. | 41.9 mio. | 26 | |
| 202201/01/2022 – 31/12/2022 | -57.9 mio. | -79.1 mio. | 91 mio. | 68.5 mio. | 27 | |
| 202101/01/2021 – 31/12/2021 | -7.8 mio. | -27.2 mio. | 106.4 mio. | 97.3 mio. | 21 | |
| 202001/01/2020 – 31/12/2020 | -7 mio. | -18.4 mio. | 81.8 mio. | 64.3 mio. | 16 | |
| 201901/01/2019 – 31/12/2019 | 2.8 mio. | -8.6 mio. | 7.8 mio. | -3.7 mio. | 15 | |
| 201801/01/2018 – 31/12/2018 | 510 t. | -9.8 mio. | 5.1 mio. | -14.3 mio. | 15 | |
| 201701/01/2017 – 31/12/2017 | 2.5 mio. | -5.1 mio. | 5.1 mio. | -4.6 mio. | 11 | |
| 201601/01/2016 – 31/12/2016 | -494 t. | -7.1 mio. | 7.6 mio. | 551 t. | 9 | |
| 201501/01/2015 – 31/12/2015 | -2.2 mio. | -6.7 mio. | 3.3 mio. | -4.9 mio. | - | |
| 201401/01/2014 – 31/12/2014 | 5.3 mio. | 226 t. | 4.3 mio. | 1.8 mio. | - | |
| 201301/01/2013 – 31/12/2013 | 5.7 mio. | 585 t. | 3.4 mio. | 1.6 mio. | - | |
| 201201/01/2012 – 31/12/2012 | 1.6 mio. | -1.8 mio. | 1.8 mio. | 1 mio. | - |
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of EXPRES2ION BIOTECHNOLOGIES ApS is 32770487.
EXPRES2ION BIOTECHNOLOGIES ApS is owned by Expres2ion Biotech Holding AB.
The management of EXPRES2ION BIOTECHNOLOGIES ApS consists of Bent Ulrich Frandsen.
The board of EXPRES2ION BIOTECHNOLOGIES ApS consists of Martin Roland Jensen, Jakob Ole Knudsen and Karin Garre, with Martin Roland Jensen as chair.
In 2025, EXPRES2ION BIOTECHNOLOGIES ApS reported a gross profit of DKK -9,158,236.
EXPRES2ION BIOTECHNOLOGIES ApS had 18 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2025. Gross profit came to DKK -9,158,236, and the net result was DKK -21,948,253.
Contact info changed: new phone: 22221019, new email: [email protected], new website: http://www.expres2ionbio.com (April 9, 2026).
Contact info changed: new phone: 22221019, new email: [email protected], new website: http://www.expres2ionbio.com (April 8, 2026).
As of April 1, 2026, Michel Jean Baijot has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of April 1, 2026, Sara Sande has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2024. Gross profit came to DKK -24,035,211, and the net result was DKK -19,830,535.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2023. Gross profit came to DKK -38,920,365, and the net result was DKK -55,629,460.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2022. Gross profit came to DKK -57,917,073, and the net result was DKK -79,149,270.
As of October 6, 2022, Allan Rosetzsky has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2021. Gross profit came to DKK -7,806,372, and the net result was DKK -27,224,687.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2020. Gross profit came to DKK -7,043,885, and the net result was DKK -18,365,182.
As of June 2, 2021, Karin Garre has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of June 2, 2021, Sara Sande has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of June 2, 2021, Gitte Laurette Pedersen-Botero has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2019. Gross profit came to DKK 2,813,678, and the net result was DKK -8,611,095.
As of May 26, 2020, EY Godkendt Revisionspartnerselskab has been appointed auditor of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 26, 2020, EY Partnership P/S has been appointed auditor of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 26, 2020, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 26, 2020, EY Partnership P/S has stepped down as auditor of EXPRES2ION BIOTECHNOLOGIES ApS.
As of December 20, 2019, Bent Ulrich Frandsen is registered as adm. dir. of EXPRES2ION BIOTECHNOLOGIES ApS.
As of December 20, 2019, Steen Søren Klysner has stepped down as adm. dir. of EXPRES2ION BIOTECHNOLOGIES ApS.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2018. Gross profit came to DKK 510,008, and the net result was DKK -9,751,775.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2017. Gross profit came to DKK 2,507,395, and the net result was DKK -5,131,946.
As of June 13, 2018, Jakob Ole Knudsen has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2016. Gross profit came to DKK -493,626, and the net result was DKK -7,120,464.
As of December 1, 2016, Charlotte Dyring has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2015. Gross profit came to DKK -2,240,109, and the net result was DKK -6,744,584.
As of May 24, 2016, Charlotte Dyring has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 24, 2016, Gitte Laurette Pedersen-Botero has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 24, 2016, Alexander R Duncan has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 24, 2016, Charlotte Dyring has stepped down as director of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 3, 2016, is registered as an owner of EXPRES2ION BIOTECHNOLOGIES ApS with an ownership share of 100%.
As of April 1, 2016, Steen Søren Klysner is registered as adm. dir. of EXPRES2ION BIOTECHNOLOGIES ApS.
As of November 26, 2015, Jesper Roested has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2014. Gross profit came to DKK 5,341,615, and the net result was DKK 225,540.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2013. Gross profit came to DKK 5,661,707, and the net result was DKK 584,999.
EXPRES2ION BIOTECHNOLOGIES ApS has published its annual report for 2012. Gross profit came to DKK 1,616,505, and the net result was DKK -1,779,867.
As of May 21, 2013, Alexander R Duncan has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 21, 2013, Martin Welschof has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of May 26, 2011, Jesper Roested has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of January 28, 2011, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of EXPRES2ION BIOTECHNOLOGIES ApS.
As of January 28, 2011, A/S PSE NR. 2857 has stepped down as auditor of EXPRES2ION BIOTECHNOLOGIES ApS.
As of September 16, 2010, Allan Rosetzsky has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of September 16, 2010, Martin Welschof has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of September 16, 2010, Charlotte Dyring has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of September 16, 2010, Willem Adriaan De Jongh has left the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of February 18, 2010, A/S PSE NR. 2857 has been appointed auditor of EXPRES2ION BIOTECHNOLOGIES ApS.
As of February 18, 2010, Charlotte Dyring has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of February 18, 2010, Willem Adriaan De Jongh has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of February 18, 2010, Martin Roland Jensen has joined the board of directors of EXPRES2ION BIOTECHNOLOGIES ApS.
As of February 18, 2010, Charlotte Dyring is registered as director of EXPRES2ION BIOTECHNOLOGIES ApS.
As of February 18, 2010, Peter Andreas Stakemann has stepped down as director of EXPRES2ION BIOTECHNOLOGIES ApS.
On February 18, 2010, the company changed its name from ApS KBURS 17 NR. 6965 to EXPRES2ION BIOTECHNOLOGIES ApS.
As of January 1, 2010, Peter Andreas Stakemann is registered as director of EXPRES2ION BIOTECHNOLOGIES ApS.
EXPRES2ION BIOTECHNOLOGIES ApS was founded on January 1, 2010.
Companies in the same industry and area
CVR 29312206
CVR 37053678
CVR 37726028
CVR 29217939
CVR 31762863
